Page last updated: 2024-11-02

oxonic acid and Cancer of Pharynx

oxonic acid has been researched along with Cancer of Pharynx in 4 studies

Oxonic Acid: Antagonist of urate oxidase.

Research Excerpts

ExcerptRelevanceReference
" We analyzed the clinical response, survival rate, acute adverse events, and late swallowing toxicity."1.51Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma. ( Ohashi, T; Ohnishi, M; Okuda, H; Takada, N; Takagi, C; Takahashi, H, 2019)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Tohyama, T1
Sakamoto, K1
Tamura, K1
Nakamura, T1
Watanabe, J1
Wakisaka, H1
Takada, Y1
Okuda, H1
Ohnishi, M1
Takahashi, H1
Takagi, C1
Takada, N1
Ohashi, T1
Taguchi, T1
Takahashi, M1
Nishimura, G1
Shiono, O1
Komatsu, M1
Sano, D1
Sakuma, Y1
Tanigaki, Y1
Kubota, A1
Taguri, M1
Hata, M1
Oridate, N1
Kuratomi, Y1
Satoh, S1
Monji, M1
Yokogawa, K1
Suzuki, K1
Shimazu, R1
Tokumaru, S1
Inokuchi, A1

Reviews

1 review available for oxonic acid and Cancer of Pharynx

ArticleYear
Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
    World journal of surgical oncology, 2020, May-28, Volume: 18, Issue:1

    Topics: Allografts; Biopsy; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Drug Combi

2020

Trials

1 trial available for oxonic acid and Cancer of Pharynx

ArticleYear
Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or Larynx.
    Japanese journal of clinical oncology, 2014, Volume: 44, Issue:12

    Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Combination

2014

Other Studies

2 other studies available for oxonic acid and Cancer of Pharynx

ArticleYear
Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma.
    Auris, nasus, larynx, 2019, Volume: 46, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; D

2019
[A comparative study of concurrent chemoradiotherapy with S-1 or CDDP for pharyngeal or laryngeal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:8

    Topics: Aged; Aged, 80 and over; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Humans; La

2010